Primary hyperparathyroidism in patients with gastric carcinoid tumors type 1: An unusual coexistence

Neuroendocrinology

Volumn 92, Issue 4, 2010, Pages 252-258

  Thomas, Dimitrios ^a   Alexandraki, Krystallenia ^a   Nikolaou, Argiro ^a   Antoniou, Stavroula ^a   Kanakis, George ^a   Zilos, Athanasios ^a   Sougioultzis, Stavros ^a   Kaltsas, Gregory ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Gastric carcinoid tumors type 1; Primary hyperparathyroidism

Indexed keywords

CALCIUM; CHROMOGRANIN A; GASTRIN; KI 67 ANTIGEN; TECHNETIUM 99M;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; ATROPHIC GASTRITIS; AUTOIMMUNITY; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GASTRIN BLOOD LEVEL; HUMAN; HYPERGASTRINEMIA; LABELING INDEX; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARATHYROID ADENOMA; PREVALENCE; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; STOMACH CARCINOID;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOID TUMOR; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; INCIDENCE; MALE; MIDDLE AGED; PARATHYROID NEOPLASMS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; YOUNG ADULT;

EID: 78649904252     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320940     Document Type: Article

References (30)

1. Modlin IM, Lye KD, Kidd M: A 5-decade analysis of 13, 715 carcinoid tumors. Cancer 2003;6:203-209.
2. Rindi G, Luinetti O, Cornaggia M, Capella C, Solcia E: Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology 1993;104:994-1006.
3. Centanni M, Marignani M, Gargano L, Corleto VD, Casini A, Delle Fave G, Andreoli M, Annibale B: Atrophic body gastritis in patients with autoimmune thyroid disease: an underdiagnosed association. Arch Intern Med 1999;159:1726-1730.
4. Modlin IM, Lye KD, Kidd M: A 50 year analysis of gastric carcinoids: small tumor or larger problem? Am J Gastroenterol 2004;99:23-32.
5. Wermers RA, Khosla S, Atkinson EJ, Hodgson SF, O'Fallon WM, Melton LJ 3rd: The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992. Ann Intern Med 1997;126:433-440.
6. Vierimaa O, Villablanca A, Alimov A, Georgitsi M, Raitila A, Vahteristo P, Larsson C, Ruokonen A, Eloranta E, Ebeling TM, Ignatius J, Aoltonen LA, Leisti J, Salmela PI: Mutation analysis of MEN1, HRPT2, CASR, CDKN1B and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition. J Endocrinol Invest 2009;32:512-518.
7. Cetani F, Pardi E, Borsari S, Viacava P, Dipollina G, Cianferotti L, Ambrogini E, Gazzerro E, Colussi G, Berti P, Miccoli P, Pinchera A, Marcocci C: Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors. J Clin Endocrinol Metab 2004;89:5583-5591.
8. Marx SJ, Simonds WF, Aqarval SK, Burns AL, Weinstein LS, Cohran C, Skarulis MC, Spiegel AM, Libutti SK, Alexander HR Jr, Chen CC, Chang R, Chandrasekharappa SC, Collins FS: Hyperparathyroidism in hereditary syndromes: special expressions and special managements. J Bone Miner Res 2002;17:37-43.
9. Rindi G, Klöppel G, Alhman H, Caplin M, Couvelard A, de Herder WW, Eriksson B, Falchetti A, Falconi M, Komminoth P, Körner M, Lopes JM, McNicol AM, Nilsson O, Perren A, Scarpa A, Scoazec JY, Wiedenmann B, Frascati Consensus Conference Participants: TNM staging of foregut (neuro) endocrine tumors: a consensus proposal including a staging system. Virchows Arch 2006;449:395-401.
10. Bilezikian JP, Potts JT Jr, Fuleihan GH, Kleerekoper M, Neer R, Peacock M, Rastad J, Silverberg SJ, Udelsman R, Wells SA: Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab 2002;87:5353-5361. (Pubitemid 36034328)
11. Alberti-Flor JJ, Halter S, Dunn GD: Multiple gastric carcinoids in a patient with a history of primary hyperparathyroidism. Am J Gastroenterol 1985;80:531-534.
12. Rode J, Dhillon AP, Cotton PB, Woolf A, O'Rhiordan J L H: Carcinoid tumor of the stomach and primary hyperparathyroidism: a new association. J Clin Pathol 1987;40:546-551.
13. Nores JM, Dalayeun JF, Remy JM, Nenna AD: Gastric carcinoid tumor and parathyroid adenoma. Gut 1988;29:689-690.
14. Corleto VD, Goebel SU, Panzuto F, Jensen RT, Delle Fave G, Annibale G: Co-existence of hyperparathyroidism, hypergastrinemia and multiple gastric carcinoids is not always due to incomplete expression of the MEN-1 syndrome. Dig Liver Dis 2003;35:585-589.
15. Christopoulos C, Balatsos V, Rotas E, Karoumpalis I, Papavasileiou D, Kontogeorgos G, Dupasquier S, Calender A, Skandalis N, Economopoulos P: The syndrome of gastric carcinoid and hyperparathyroidism: a family study and literature review. Eur J Endocrinol 2009;160:689-694.
16. Fujimori M, Ikeda S, Shimizu Y, Okajima M, Asahara T: Accumulation of beta-catenin protein and mutations in exon 3 of betacatenin gene in gastrointestinal carcinoid tumor. Cancer Res 2001;61:6656-6659.
17. Bjorklund P, Linddberg D, Akerstrom G, Westin G: Stabilizing mutation of CTNNB1/beta-catenin and protein accumulation analyzed in a large series of parathyroid tumors of Swedish patients. Mol Cancer 2008;7:53.
18. Erickson LA, Jin L, Wollan P, Thompson GB, van Heerden JA, Lloyd RV: Parathyroid hyperplasia, adenomas, and carcinomas: differential expression of p27Kip1 protein. Am J Surg Pathol 1999;23:288-295.
19. Doganavsargil B, Sarsik B, Kirdok FS, Musoglu A, Tuncyurek M: p21 and p27 immunoexpression in gastric well-differentiated endocrine tumors (ECL-cell carcinoids). World J Gastroenterol 2006;12:6280-6284.
20. Sorensen OH, Hindberg I, Madsen SN: Secondary hyperparathyroidism in young rats given prolonged treatment with calcitonin. Acta Endocrinol 1972;71:313-320.
21. Erdogan MF, Gursoy A, Kulaksizoglu M: Long-term effects of elevated gastrin levels on calcitonin secretion. J Endocrinol Invest 2006;29:771-775.
22. Selking O, Borch K, Johanson H, Ljunghall S, Wide L: Evaluation of parathyroid function in patients with hypergastrinemia and pernicious anemia. Upsala J Med Sci 1982;87:215-222.
23. Dufresne M, Seva C, Fourmy D: Cholecystokinine and gastrin receptors. Physiol Rev 2006;86:805-847.
24. Reubi JC, Schaer JC, Waser B: Cholecystokinine (CCK)-A and CCK-B/gastrin receptors in human tumors. Cancer Res 1997;57:1377-1386.
25. Gagnemo-Persson R, Samuelsson A, Hakanson R, Persson P: Chicken parathyroid hormone gene expression in response to gastrin, omeprazole, ergocalciferol, and restricted food intake. Calcified Tissue Int 1997;61:210-215.
26. Polak JM, Bussolati G, Pearse A G E: Cytochemical, immunofluorescence and ultrastructural investigation on the antral G cells in hyperparathyroidism. Virchows Arch 1971;9:187-197.
27. Creutzfeld W, Arnold R, Creutzfeld C, Feurle G, Ketterer H: Gastrin and G cells in the antral mucosa of patients with pernicious anaemia, acromegaly and hyperparathyroidism and in Zollinger-Ellison tumor of the pancreas. Eur J Clin Invest 1971;1:461-479.
28. Buchan AM, Squires P, Ring M, Meloche RM: Mechanism of action of the calciumsensing receptor in human antral gastrin cells. Gastroenterolgy 2001;120:1279-1281.
29. Corleto VD, Minisola S, Moretti A, Damiani C, Grossi C, Ciardi S, D'Ambra G, Bordi C, Strom R, Spagna G, Delle Fave G, Annibale B: Prevalence and causes of hypergastrinemia in primary hyperparathyroidism: a prospective study. J Clin Endocrinol Metab 1999;84:4554-4558.
30. Kagawa J, Honda S, Kodama M, Sato R, Murakami K, Fujioka T: Enterochromaffin-like cell tumor induced by Helicobacter pylori infection in Mongolian gerbils. Helicobacter 2002;7:390-397.